From: Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
DataSet | Sample Size | Platform | clinical Data | Note |
---|---|---|---|---|
ICGCarray | 178 | Illumina | Yes | Training set |
TCGA | 172 | RNA-Seq | Yes | Training set |
MTAB-1791 | 195 | Illumina | No | Training set |
GSE62165 | 118 | Affymetrix | No | Training set |
GSE60980 | 49 | Agilent-028004 | No | Training set |
GSE15471 | 39 | Affymetrix, plus2 | No | Training set |
GSE55643 | 45 | Agilent-014850 | No | Training set |
Bailey | 71 | RNA-Seq | Yes | Validation set |
GSE71729 | 145 | Agilent-014850 | Yes | Validation set |
GSE57495 | 63 | Rosetta/Merck | Yes | Validation set |
GSE79670 | 51 | RNA-Seq | Yes | Validation set |
GSE62452 | 69 | Affymetrix | Yes | Validation set |
Collisson | 27 | Affymetrix, plus2 | Yes | Validation set |
GSE77858 | 46 | Agilent-012097 | No | Validation set |